Aspirin 300mg

DRUG3 trials

Sponsors

University College, London, NHS Lothian, Instituto Mexicano del Seguro Social

Conditions

Anticoagulant-induced BleedingBreast CancerCancerColorectal CancerEczemaGastro-oesophageal CancerProstate CancerPulmonary Embolism

Phase 2

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

CompletedNCT05515120

Instituto Mexicano del Seguro SocialAnticoagulant-induced Bleeding, Pulmonary Embolism, Venous Thromboembolism +1

Start: 2021-01-03End: 2022-07-01Updated: 2022-08-25

Phase 3

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Active, not recruitingNCT02804815

University College, LondonBreast Cancer, Cancer, Colorectal Cancer +2

Start: 2015-10-31End: 2026-10-31Target: 11000Updated: 2025-06-10

Unknown Phase

PGE2/IL-22 Pathway in Various Forms of Eczema

CompletedNCT04133506

NHS LothianEczema

Start: 2021-11-04End: 2025-11-30Updated: 2026-02-10